Efficacy and Safety of Sofosbuvir Plus Daclatasvir in Chinese Treatment-experienced Patients With Chronic Genotype 1b HCV Infection
Phase of Trial: Phase II/III
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 Jan 2017 Last checked against ClinicalTrials.gov record.
- 15 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 15 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.